Related Experiment Video
Updated: May 30, 2025

06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
30.5K
Challenges for complement functional assays in the clinical laboratory: From test validation to clinical
Vijayalakshmi Nandakumar1, Karin M P Braun2, Maria Alice V Willrich2
1Exsera BioLabs, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Journal of Immunological Methods
|January 25, 2025
Summary
Complement functional assays are crucial for diagnosing immune disorders but face challenges due to protein instability. Standardization is needed for accurate laboratory assessment and personalized treatment.
Area of Science:
- Clinical immunology
- Laboratory medicine
- Complement system biology
Background:
- Complement functional assays are vital for diagnosing diverse disorders, including immune deficiencies, autoimmune diseases, and thrombotic microangiopathies.
- These assays assess complement pathways and components, aiding in diagnosis and disease monitoring.
- The increasing use of complement inhibitors necessitates reliable laboratory assessment of treatment efficacy.
Purpose of the Study:
- To discuss the challenges and limitations of current complement functional assays.
- To highlight the need for standardization and improved practices in clinical laboratories.
- To address the demand for personalized treatment plans through accurate complement assessment.
Main Methods:
- Review of current complement functional assay methodologies.
- Discussion of pre-analytical and analytical challenges.
- Analysis of regulatory status and validation requirements for laboratory-developed tests (LDTs).
Main Results:
- Complement proteins are labile, requiring strict handling protocols (prompt processing, cold centrifugation, -80°C storage).
- Only one FDA-approved complement functional test exists; others are LDTs requiring rigorous validation.
- Harmonization across laboratories is hindered by varying methodologies and calibrators.
Conclusions:
- Complement functional assays are essential but technically demanding.
- Standardization and improved laboratory practices are critical for reliable complement testing.
- Further development and validation of assays are needed to support personalized medicine and complement inhibitor therapy.
Related Concept Videos
Complementation Tests
4.8K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
4.8K
Enzyme-Linked Immunosorbent Assay
12.4K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
12.4K

